Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Prostaglandin E2 Receptor EP4 Subtype Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Prostaglandin E2 Receptor EP4 Subtype Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Prostaglandin E2 Receptor EP4 Subtype Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Type
    • 1.4.2 E-7046
    • 1.4.3 ER-886046
    • 1.4.4 grapiprant
    • 1.4.5 KAG-308
    • 1.4.6 ONO-4232
    • 1.4.7 Others
  • 1.5 Market by Application
    • 1.5.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Application
    • 1.5.2 Breast Cancer
    • 1.5.3 Allergies
    • 1.5.4 Chronic Pain
    • 1.5.5 Acute Pain
    • 1.5.6 Lung Cancer
    • 1.5.7 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size, Estimates and Forecasts
    • 2.1.1 Global Prostaglandin E2 Receptor EP4 Subtype Revenue 2015-2026
    • 2.1.2 Global Prostaglandin E2 Receptor EP4 Subtype Sales 2015-2026
  • 2.2 Global Prostaglandin E2 Receptor EP4 Subtype, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Prostaglandin E2 Receptor EP4 Subtype Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Prostaglandin E2 Receptor EP4 Subtype Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Prostaglandin E2 Receptor EP4 Subtype Competitor Landscape by Players

  • 3.1 Prostaglandin E2 Receptor EP4 Subtype Sales by Manufacturers
    • 3.1.1 Prostaglandin E2 Receptor EP4 Subtype Sales by Manufacturers (2015-2020)
    • 3.1.2 Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Prostaglandin E2 Receptor EP4 Subtype Revenue by Manufacturers
    • 3.2.1 Prostaglandin E2 Receptor EP4 Subtype Revenue by Manufacturers (2015-2020)
    • 3.2.2 Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Prostaglandin E2 Receptor EP4 Subtype Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Prostaglandin E2 Receptor EP4 Subtype Revenue in 2019
    • 3.2.5 Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Prostaglandin E2 Receptor EP4 Subtype Price by Manufacturers
  • 3.4 Prostaglandin E2 Receptor EP4 Subtype Manufacturing Base Distribution, Product Types
    • 3.4.1 Prostaglandin E2 Receptor EP4 Subtype Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Prostaglandin E2 Receptor EP4 Subtype Product Type
    • 3.4.3 Date of International Manufacturers Enter into Prostaglandin E2 Receptor EP4 Subtype Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020)
    • 4.1.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales by Type (2015-2020)
    • 4.1.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2015-2020)
    • 4.1.3 Prostaglandin E2 Receptor EP4 Subtype Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Forecast by Type (2021-2026)
    • 4.2.3 Prostaglandin E2 Receptor EP4 Subtype Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020)
    • 5.1.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales by Application (2015-2020)
    • 5.1.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2015-2020)
    • 5.1.3 Prostaglandin E2 Receptor EP4 Subtype Price by Application (2015-2020)
  • 5.2 Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Prostaglandin E2 Receptor EP4 Subtype Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Prostaglandin E2 Receptor EP4 Subtype by Country
    • 6.1.1 North America Prostaglandin E2 Receptor EP4 Subtype Sales by Country
    • 6.1.2 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Prostaglandin E2 Receptor EP4 Subtype Market Facts & Figures by Type
  • 6.3 North America Prostaglandin E2 Receptor EP4 Subtype Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Prostaglandin E2 Receptor EP4 Subtype by Country
    • 7.1.1 Europe Prostaglandin E2 Receptor EP4 Subtype Sales by Country
    • 7.1.2 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Facts & Figures by Type
  • 7.3 Europe Prostaglandin E2 Receptor EP4 Subtype Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype by Region
    • 8.1.1 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Sales by Region
    • 8.1.2 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Market Facts & Figures by Type
  • 8.3 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Prostaglandin E2 Receptor EP4 Subtype by Country
    • 9.1.1 Latin America Prostaglandin E2 Receptor EP4 Subtype Sales by Country
    • 9.1.2 Latin America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Prostaglandin E2 Receptor EP4 Subtype Market Facts & Figures by Type
  • 9.3 Central & South America Prostaglandin E2 Receptor EP4 Subtype Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype by Country
    • 10.1.1 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Sales by Country
    • 10.1.2 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Market Facts & Figures by Type
  • 10.3 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Eisai Co Ltd
    • 11.1.1 Eisai Co Ltd Corporation Information
    • 11.1.2 Eisai Co Ltd Description and Business Overview
    • 11.1.3 Eisai Co Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Products Offered
    • 11.1.5 Eisai Co Ltd Related Developments
  • 11.2 Eli Lilly and Co
    • 11.2.1 Eli Lilly and Co Corporation Information
    • 11.2.2 Eli Lilly and Co Description and Business Overview
    • 11.2.3 Eli Lilly and Co Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Products Offered
    • 11.2.5 Eli Lilly and Co Related Developments
  • 11.3 Kaken Pharmaceutical Co Ltd
    • 11.3.1 Kaken Pharmaceutical Co Ltd Corporation Information
    • 11.3.2 Kaken Pharmaceutical Co Ltd Description and Business Overview
    • 11.3.3 Kaken Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Products Offered
    • 11.3.5 Kaken Pharmaceutical Co Ltd Related Developments
  • 11.4 Ono Pharmaceutical Co Ltd
    • 11.4.1 Ono Pharmaceutical Co Ltd Corporation Information
    • 11.4.2 Ono Pharmaceutical Co Ltd Description and Business Overview
    • 11.4.3 Ono Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Products Offered
    • 11.4.5 Ono Pharmaceutical Co Ltd Related Developments
  • 11.5 RaQualia Pharma Inc
    • 11.5.1 RaQualia Pharma Inc Corporation Information
    • 11.5.2 RaQualia Pharma Inc Description and Business Overview
    • 11.5.3 RaQualia Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Products Offered
    • 11.5.5 RaQualia Pharma Inc Related Developments
  • 11.6 Rottapharm Biotech Srl
    • 11.6.1 Rottapharm Biotech Srl Corporation Information
    • 11.6.2 Rottapharm Biotech Srl Description and Business Overview
    • 11.6.3 Rottapharm Biotech Srl Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Products Offered
    • 11.6.5 Rottapharm Biotech Srl Related Developments
  • 11.1 Eisai Co Ltd
    • 11.1.1 Eisai Co Ltd Corporation Information
    • 11.1.2 Eisai Co Ltd Description and Business Overview
    • 11.1.3 Eisai Co Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Products Offered
    • 11.1.5 Eisai Co Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Prostaglandin E2 Receptor EP4 Subtype Market Estimates and Projections by Region
    • 12.1.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Forecast by Regions 2021-2026
  • 12.2 North America Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast (2021-2026)
    • 12.2.1 North America: Prostaglandin E2 Receptor EP4 Subtype Sales Forecast (2021-2026)
    • 12.2.2 North America: Prostaglandin E2 Receptor EP4 Subtype Revenue Forecast (2021-2026)
    • 12.2.3 North America: Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Prostaglandin E2 Receptor EP4 Subtype Sales Forecast (2021-2026)
    • 12.3.2 Europe: Prostaglandin E2 Receptor EP4 Subtype Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Prostaglandin E2 Receptor EP4 Subtype Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Prostaglandin E2 Receptor EP4 Subtype Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Prostaglandin E2 Receptor EP4 Subtype Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Prostaglandin E2 Receptor EP4 Subtype Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Prostaglandin E2 Receptor EP4 Subtype Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Prostaglandin E2 Receptor EP4 Subtype Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Prostaglandin E2 Receptor EP4 Subtype Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Prostaglandin E2 Receptor EP4 Subtype Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Prostaglandin E2 Receptor EP4 Subtype Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Prostaglandin E2 Receptor EP4 Subtype market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostaglandin E2 Receptor EP4 Subtype market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Prostaglandin E2 Receptor EP4 Subtype market is segmented into
    E-7046
    ER-886046
    grapiprant
    KAG-308
    ONO-4232
    Others

    Segment by Application, the Prostaglandin E2 Receptor EP4 Subtype market is segmented into
    Breast Cancer
    Allergies
    Chronic Pain
    Acute Pain
    Lung Cancer
    Others

    Regional and Country-level Analysis
    The Prostaglandin E2 Receptor EP4 Subtype market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Prostaglandin E2 Receptor EP4 Subtype market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Prostaglandin E2 Receptor EP4 Subtype Market Share Analysis
    Prostaglandin E2 Receptor EP4 Subtype market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prostaglandin E2 Receptor EP4 Subtype business, the date to enter into the Prostaglandin E2 Receptor EP4 Subtype market, Prostaglandin E2 Receptor EP4 Subtype product introduction, recent developments, etc.

    The major vendors covered:
    Eisai Co Ltd
    Eli Lilly and Co
    Kaken Pharmaceutical Co Ltd
    Ono Pharmaceutical Co Ltd
    RaQualia Pharma Inc
    Rottapharm Biotech Srl
    ...

    Buy now